Tatiana P. Morais

Tatiana P. Morais

Auto-generated profile, based on publicly available information

Tatiana P. Morais

Neuroscience Division, School of Bioscience, Cardiff University, Cardiff, UK; Faculdade de Medicina, Instituto de Farmacologia e Neurociências, Universidade de Lisboa, Lisboa, Portugal; Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2021 in Epilepsia
Verified
Journal Article
Open access
PDF file
YIYasmine Iacone
Yasmine Iacone
TMTatiana P. Morais
Tatiana P. Morais
FDFrançois David
François David
FDFrancis Delicata
Francis Delicata
JSJoanna Sandle
Joanna Sandle
MLMagor Lőrincz
Magor Lőrincz
Objective: Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are known to be involved in the generation of absence seizures (ASs), and there is evidence that cortical and thalamic HCN channel dysfunctions may have a proabsence role. Many HCN channel blockers are available, but their role in ASs has been investigated only by localized brain injection or in in vitro model systems due to their limited brain availability. Here, we investigated the effect on ASs of orally administered ivabradine (an HCN channel blocker approved for the treatment of heart failure in humans) following injection of the P‐glycoprotein inhibitor elacridar, which is known to increase penetration into the brain of drug substrates for this efflux transporter. The action of ivabradine was also tested following in vivo microinjection into the cortical initiation network (CIN) of the somatosensory cortex and in the thalamic ventrobasal nucleus (VB) as well as on cortical and thalamocortical neurons in brain slices.Methods: We used electroencephalographic recordings in freely moving Genetic Absence Epilepsy Rats From Strasbourg (GAERSs) to assess the action of oral administration of ivabradine, with and without elacridar, on ASs. Ivabradine was also microinjected into the CIN and VB of GAERSs in vivo and applied to Wistar CIN and GAERS VB slices while recording patch‐clamped cortical Layer 5/6 and thalamocortical neurons, respectively.Results: Oral administration of ivabradine markedly and dose‐dependently reduced ASs. Ivabradine injection into CIN abolished ASs and elicited small‐amplitude 4–7‐Hz waves (without spikes), whereas in the VB it was less potent. Moreover, ivabradine applied to GAERS VB and Wistar CIN slices selectively decreased HCN channel‐dependent properties of cortical Layer 5/6 pyramidal and thalamocortical neurons, respectively.Significance: These results provide the first demonstration of the antiabsence action of a systemically administered HCN channel blocker, indicating the potential of this class of drugs as a novel therapeutic avenue for ASs.

17 January 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
TMTatiana P. Morais
Tatiana P. Morais
DCDavid Coelho
David Coelho
SVSandra H. Vaz
Sandra H. Vaz
ASAna M. Sebastião
Ana M. Sebastião
CVCláudia A. Valente
Cláudia A. Valente
In central nervous system, glycine receptor (GlyR) is mostly expressed in the spinal cord and brainstem, but glycinergic transmission related elements have also been identified in the brain. Astrocytes are active elements at the tripartite synapse, being responsible for the maintenance of brain homeostasis and for the fine-tuning of synaptic activity. These cells communicate, spontaneously or in response to a stimulus, by elevations in their cytosolic calcium (calcium transients, Ca2+T) that can be propagated to other cells. How these Ca2+T are negatively modulated is yet poorly understood. In this work, we evaluated GlyR expression and its role on calcium signaling modulation in rat brain astrocytes. We first proved that GlyR, predominantly subunits α2 and β, was expressed in brain astrocytes and its localization was confirmed in the cytoplasm and astrocytic processes by immunohistochemistry assays. Calcium imaging experiments in cultured astrocytes showed that glycine (500 μM), a GlyR agonist, caused a concentration-dependent reduction in ATP-induced Ca2+T, an effect abolished by the GlyR antagonist, strychnine (0.8 μM), as well as by nocodazole (1 μM), known to impair GlyR anchorage to the plasma membrane. This effect was mimicked by activation of GABAAR, another Cl--permeable channel. In summary, we demonstrated that GlyR activation in astrocytes mediates an inhibitory effect upon ATP induced Ca2+T, which most probably involves changes in membrane permeability to Cl- and requires GlyR anchorage at the plasma membrane. GlyR in astrocytes may thus be part of a mechanism to modulate astrocyte-to-neuron communication.

11 June 2026 in Neuropharmacology
Verified
Journal Article
Open access
VCVincenzo Crunelli
Vincenzo Crunelli
TMTatiana P. Morais
Tatiana P. Morais
WCWilliam M. Connelly
William M. Connelly
Giulia SalamancaGiulia Salamanca
Giulia Salamanca
SVSandra H. Vaz
Sandra H. Vaz
Giuseppe Di GiovanniGiuseppe Di Giovanni
Giuseppe Di Giovanni
Renewed interest in psychedelic therapeutics has brought serotonin 5-HT2A receptors (5-HT2ARs) back into focus. Given the role of the thalamus in sensory integration and network synchronization, we examined the expression, developmental regulation, and functional impact of thalamic 5-HT2ARs, with particular emphasis on their interaction with extrasynaptic GABAA receptors and the generation of aberrant thalamocortical rhythms in Wistar rats. Immunofluorescence revealed a developmental increase of 5-HT2AR expression in both the reticular thalamic nucleus (NRT) and ventrobasal (VB) thalamus, that is accompanied by a shift in VB expression from GABAergic interneurons in juveniles to thalamocortical (TC) neurons in adults. Astrocyte density increased in both regions, more prominently in the NRT than in the VB, with approximately half of astrocytes expressing 5-HT2ARs regardless of age or region. Activation of 5-HT2ARs with the potent agonist TCB-2 reduced thalamic GABA uptake, an effect that was occluded in the presence of GAT1 inhibitor NO711. Patch-clamp recordings showed that TCB-2 enhanced tonic GABAA currents in VB TC neurons. This effect was absent in δ-subunit KO mice and was unaffected by blockade of postsynaptic G-protein signaling or phospholipase C pathways in TC neurons, suggesting that it is not dependent on postsynaptic signaling mechanisms. EEG recordings in freely moving rats showed that bilateral microinjection of TCB-2 into the VB induced spike-and-wave discharges accompanied by behavioral arrest that were blocked by ethosuximide, indicating that they were absence seizures. In summary, these findings support a mechanism, through which serotonergic signaling via 5-HT2ARs can shape thalamocortical network dynamics and increase susceptibility to aberrant rhythmic activity, which could potentially occur under conditions of altered serotonergic tone.

5 May 2026 in Epilepsia
Verified
Journal Article
Closed access
TMTatiana P. Morais
Tatiana P. Morais
Giulia SalamancaGiulia Salamanca
Giulia Salamanca
SVSandra H. Vaz
Sandra H. Vaz
ASAna M. Sebastião
Ana M. Sebastião
CBCristiano Bombardi
Cristiano Bombardi
Giuseppe Di GiovanniGiuseppe Di Giovanni
Giuseppe Di Giovanni